Top

Current Bladder Dysfunction Reports

Published in:

Open Access 19-08-2023 | Overactive Bladder

The Intersection of Female Sexual Function and Overactive Bladder

Authors: Poone S. Shoureshi, Karyn S. Eilber

Published in: Current Bladder Dysfunction Reports | Issue 3/2023

Abstract

Purpose of Review

In this review, we discuss the available literature regarding the intersection of female sexual function and overactive bladder (OAB). Specifically, this review includes how OAB and its treatments affect female sexual function and quality of life.

Recent Findings

Women suffering from overactive bladder have worse sexual function, and there are multiple prospective studies evaluating sexual function before and after overactive bladder treatment.

Summary

There is a growing body of evidence demonstrating that traditional overactive bladder treatments not only improve OAB but can also improve sexual function.

Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology. 2010;75(3):526–532.e18. https://doi.org/10.1016/j.urology.2009.06.096.CrossRefPubMed

Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760–6. https://doi.org/10.1046/j.1464-410x.2001.02228.x.CrossRefPubMed

Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26. https://doi.org/10.1007/s00192-009-0976-9.CrossRefPubMed

Erekson EA, Ciarleglio MM, Hanissian PD, Strohbehn K, Bynum JPW, Fried TR. Functional disability and compromised mobility among older women with urinary incontinence. Female Pelvic Med Reconstr Surg. 2015;21(3):170–5. https://doi.org/10.1097/SPV.0000000000000136.CrossRefPubMedPubMedCentral

Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388–95. https://doi.org/10.1111/j.1464-410X.2008.07601.x.CrossRefPubMed

Donaldson MM, Thompson JR, Matthews RJ, Dallosso HM, CW MG. The natural history of overactive bladder and stress urinary incontinence in older women in the community: a 3-year prospective cohort study. Neurourol Urodyn. 2006;25(7):709–16. https://doi.org/10.1002/nau.20235.CrossRefPubMed

La Rosa VL, Platania A, Ciebiera M, et al. A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being. Prz Menopauzalny. 2019;18(2):89–93. https://doi.org/10.5114/pm.2019.86834.CrossRefPubMedPubMedCentral

Temml C, Haidinger G, Schmidbauer J, Schatzl G, Madersbacher S. Urinary incontinence in both sexes: prevalence rates and impact on quality of life and sexual life. Neurourol Urodyn. 2000;19(3):259–71.https://doi.org/10.1002/(SICI)1520-6777(2000)19:3<259::AID-NAU7>3.0.CO;2-U .

Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol. 2006;195(6):1730–5. https://doi.org/10.1016/j.ajog.2006.08.013.CrossRefPubMed

10.

Ge TJ, Vetter J, Lai HH. Sleep disturbance and fatigue are associated with more severe urinary incontinence and overactive bladder symptoms. Urology. 2017;109:67–73. https://doi.org/10.1016/j.urology.2017.07.039.CrossRefPubMed

11.

Lai HH, Shen B, Rawal A, Vetter J. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. BMC Urol. 2016;16(1):60. https://doi.org/10.1186/s12894-016-0179-x.CrossRefPubMedPubMedCentral

12.

Zahariou A, Karamouti M, Tyligada E, Papaioannou P. Sexual function in women with overactive bladder. Urogynecology. 2010;16(1):31. https://doi.org/10.1097/SPV.0b013e3181bf51eb.CrossRef

13.

Wang Y, Shi C, Wang Y, et al. The correlation between severity of overactive bladder symptoms with female sexual dysfunction and sexual satisfaction of partners. Urol Int. 2021;105(1-2):124–30. https://doi.org/10.1159/000508764.CrossRefPubMed

14.••

Balzarro M, Rubilotta E, Mancini V, et al. Impact of overactive bladder-wet syndrome on female sexual function: a systematic review and meta-analysis. Sex Med Rev. 2019;7(4):565–74. https://doi.org/10.1016/j.sxmr.2019.05.002. Systematic review and meta-analysis of prior published work about OAB and FSD.CrossRefPubMed

15.

Jha S, Strelley K, Radley S. Incontinence during intercourse: myths unravelled. Int Urogynecol J. 2012;23(5):633–7. https://doi.org/10.1007/s00192-011-1583-0.CrossRefPubMed

16.

Oh SJ, Ku JH, Choo MS, Yun JM, Kim DY, Park WH. Health-related quality of life and sexual function in women with stress urinary incontinence and overactive bladder. Int J Urol. 2008;15(1):62–7; discussion 67. https://doi.org/10.1111/j.1442-2042.2007.01905.x.CrossRefPubMed

17.

Madhu C, Hashim H, Enki D, Yassin M, Drake M. Coital incontinence: what can we learn from urodynamic assessment? Urology. 2015;85(5):1034–8. https://doi.org/10.1016/j.urology.2015.02.007.CrossRefPubMed

18.

Duralde ER, Rowen TS. Urinary incontinence and associated female sexual dysfunction. Sex Med Rev. 2017;5(4):470–85. https://doi.org/10.1016/j.sxmr.2017.07.001.CrossRefPubMed

19.

Lin XD, Lin N, Ke ZB, Xu N, Jiang P, Li H. Effects of overactive bladder syndrome on female sexual function. Medicine (Baltimore). 2021;100(20):e25761. https://doi.org/10.1097/MD.0000000000025761.CrossRefPubMedPubMedCentral

20.

Ambikairajah A, Walsh E, Cherbuin N. A review of menopause nomenclature. Reprod Health. 2022;19(1):29. https://doi.org/10.1186/s12978-022-01336-7.CrossRefPubMedPubMedCentral

21.

Blümel JE, Chedraui P, Baron G, et al. Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index. Menopause. 2009;16(6):1139–48. https://doi.org/10.1097/gme.0b013e3181a4e317.CrossRefPubMed

22.

Dąbrowska-Galas M, Dąbrowska J, Michalski B. Sexual dysfunction in menopausal women. Sex Med. 2019;7(4):472–9. https://doi.org/10.1016/j.esxm.2019.06.010.CrossRefPubMedPubMedCentral

23.

Robinson D, Cardozo L, Milsom I, et al. Oestrogens and overactive bladder. Neurourol Urodyn. 2014;33(7):1086–91. https://doi.org/10.1002/nau.22464.CrossRefPubMed

24.•

Peyronnet B, Mironska E, Chapple C, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988–1000. https://doi.org/10.1016/j.eururo.2019.02.038. Overview of pathophysiology of OAB.CrossRefPubMed

25.

Juliato CRT, Melotti IGR, Junior LCS, Britto LGO, Riccetto CLZ. Does the severity of overactive bladder symptoms correlate with risk for female sexual dysfunction? J Sex Med. 2017;14(7):904–9. https://doi.org/10.1016/j.jsxm.2017.05.005.CrossRefPubMed

26.

Chugtai B, Forde JC, Buck J, et al. The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in menopausal women. Post Reprod Health. 2016;22(1):34–40.CrossRef

27.

Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019 Sep;202(3):558–63. https://doi.org/10.1097/JU.0000000000000309.CrossRefPubMed

28.

Shafik A, Shafik IA. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol. 2003;20(6):374–7. https://doi.org/10.1007/s00345-002-0309-9.CrossRefPubMed

29.

Omodei MS. Marques Gomes Delmanto LR, Carvalho-Pessoa E, Schmitt EB, Nahas GP, Petri Nahas EA. Association between pelvic floor muscle strength and sexual function in postmenopausal women. J Sex Med. 2019;16(12):1938–46. https://doi.org/10.1016/j.jsxm.2019.09.014.CrossRefPubMed

30.

Sartori DVB, Kawano PR, Yamamoto HA, Guerra R, Pajolli PR, Amaro JL. Pelvic floor muscle strength is correlated with sexual function. Investig Clin Urol. 2021;62(1):79. https://doi.org/10.4111/icu.20190248.CrossRefPubMed

31.

Zachariou A, Filiponi M. The effect of extended release tolterodine used for overactive bladder treatment on female sexual function. Int Braz J Urol. 2017;43:713–20. https://doi.org/10.1590/S1677-5538.IBJU.2016.0303.CrossRefPubMedPubMedCentral

32.•

Cakir SS, Degirmentepe RB, Atalay HA, et al. The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study. Int Urol Nephrol. 2019;51(1):27–32. https://doi.org/10.1007/s11255-018-2030-7. Prospective study evaluating anticholinergics and FSD.CrossRefPubMed

33.••

Zachariou A, Mamoulakis C, Filiponi M, et al. The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study. BMC Urol. 2018;18(1):61. https://doi.org/10.1186/s12894-018-0377-9. Prospective study evaluating mirabegron and FSD.CrossRefPubMedPubMedCentral

34.

Polland A, Hamner JJ, Arunachalam D, et al. STOMp: sexual function trial of overactive bladder medication. Sex Med. 2023;11(1):qfac001. https://doi.org/10.1093/sexmed/qfac001. STOMp trial: comparing sexual function in women on anticholinergics versus beta-agonists for OAB.CrossRefPubMedPubMedCentral

35.

Kershaw V, Khunda A, McCormick C, Ballard P. The effect of percutaneous tibial nerve stimulation (PTNS) on sexual function: a systematic review and meta-analysis. Int Urogynecol J. 2019;30(10):1619–27. https://doi.org/10.1007/s00192-019-04027-3.CrossRefPubMed

36.

Gill BC, Swartz MA, Firoozi F, et al. Improved sexual and urinary function in women with sacral nerve stimulation. Neuromodulation: Technol Neural Interface. 2011;14(5):436–43. https://doi.org/10.1111/j.1525-1403.2011.00380.x.CrossRef

37.

van Voskuilen AC, Oerlemans DJ, Gielen N, et al. Sexual response in patients treated with sacral neuromodulation for lower urinary tract symptoms or fecal incontinence. UIN. 2012;88(4):423–30. https://doi.org/10.1159/000336911.CrossRef

38.

Pauls RN, Marinkovic SP, Silva WA, Rooney CM, Kleeman SD, Karram MM. Effects of sacral neuromodulation on female sexual function. Int Urogynecol J. 2007;18(4):391–5. https://doi.org/10.1007/s00192-006-0168-9.CrossRef

39.

Banakhar M, Gazwani Y, Kelini ME, Al-Shaiji T, Hassouna M. Effect of sacral neuromodulation on female sexual function and quality of life: are they correlated? Can Urol Assoc J. 2014;8(11-12):E762–7. https://doi.org/10.5489/cuaj.2300.CrossRefPubMedPubMedCentral

40.

Wenzler DL, Burks FN, Cooney M, Peters KM. Proof of concept trial on changes in current perception threshold after sacral neuromodulation. Neuromodulation. 2015;18(3):228–32. https://doi.org/10.1111/ner.12213.CrossRefPubMed

41.

Dasgupta R, Critchley HD, Dolan RJ, Fowler CJ. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005;174(6):2268–72. https://doi.org/10.1097/01.ju.0000181806.59363.d1.CrossRefPubMed

42.••

Khunda A, McCormick C, Ballard P. Sacral neuromodulation and sexual function: a systematic review and meta-analysis of the literature. Int Urogynecol J. 2019;30(3):339–52. https://doi.org/10.1007/s00192-018-3841-x. Systematic review and meta-analysis of published work about sacral neuromodulation and sexual function.CrossRefPubMed

43.

Parnell BA, Howard JF Jr, Geller EJ. The effect of sacral neuromodulation on pudendal nerve function and female sexual function. Neurourol Urodyn. 2015;34(5):456–60. https://doi.org/10.1002/nau.22579.CrossRefPubMed

44.

Miotla P, Cartwright R, Skorupska K, et al. Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB. Neurourol Urodyn. 2017;36(6):1564–9. https://doi.org/10.1002/nau.23148.CrossRefPubMed

45.

Giannantoni A, Proietti S, Giusti G, et al. OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results. World J Urol. 2015;33(12):2095–101. https://doi.org/10.1007/s00345-015-1578-4.CrossRefPubMed

46.

Lin YH, Hsieh WC, Huang L, Liang CC. Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwanese J Obstet Gynecol. 2017;56(6):815–20. https://doi.org/10.1016/j.tjog.2017.10.020.CrossRefPubMed

47.

Giuseppe PG, Pace G, Vicentini C. Sexual function in women with urinary incontinence treated by pelvic floor transvaginal electrical stimulation. J Sex Med. 2007;4(3):702–7. https://doi.org/10.1111/j.1743-6109.2006.00318.x.CrossRefPubMed

Title: The Intersection of Female Sexual Function and Overactive Bladder
Authors: Poone S. Shoureshi
Karyn S. Eilber
Publication date: 19-08-2023
Publisher: Springer US
Keywords: Overactive Bladder
Urinary Incontinence
Urinary Incontinence
Nerve Stimulation
Published in: Current Bladder Dysfunction Reports / Issue 3/2023
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-023-00704-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Intersection of Female Sexual Function and Overactive Bladder

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 3/2023

Management of Elevated Post-Void Residual Volume

Neuromodulation Following Spinal Cord Injury for Restoration of Bladder and Erectile Function

Impact of Neurogenic Lower Urinary Tract Dysfunction on Bowel Symptoms

Management of Vaginal Prolapse After Orthotopic Bladder

Overactive Bladder Medication Prescribing Trends in the Era of Known Cognitive Effects from Anticholinergic Drugs

Risks of Bladder Cancer in Patients with Childhood Augmentation or Chronic Catheters for Neurogenic Bladder